CARGO Therapeutics Price Target Announced at $33.00/Share by HC Wainwright & Co.
CARGO Therapeutics Price Target Announced at $33.00/Share by HC Wainwright & Co.
H.C. Wainwright Initiates CARGO Therapeutics(CRGX.US) With Buy Rating, Announces Target Price $33
H.C. Wainwright analyst Robert Burns initiates coverage on $CARGO Therapeutics(CRGX.US)$ with a buy rating, and sets the target price at $33.According to TipRanks data, the analyst has a success
Express News | CARGO Therapeutics, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating
CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
Ongoing Phase 1 study informed dose selection for CARGO's currently enrolling, potentially pivotal Phase 2 clinical study, FIRCE-1 of firicabtagene autoleucel (firi-cel)1, in patients with relapsed or refractory (R/R)
Cargo Therapeutics Shares Rise on Sublease Deal With Vaxcyte
By Sabela Ojea Shares of Cargo Therapeutics rose 6.1% in post-market trading after the company entered a sublease agreement with Vaxcyte. The stock recently traded at $16.97. Shares are down about 31%
CARGO Therapeutics Price Target Announced at $28.00/Share by Chardan Capital
CARGO Therapeutics Price Target Announced at $28.00/Share by Chardan Capital
Chardan Capital Initiates CARGO Therapeutics(CRGX.US) With Buy Rating, Announces Target Price $28
Chardan Capital analyst Geulah Livshits initiates coverage on $CARGO Therapeutics(CRGX.US)$ with a buy rating, and sets the target price at $28.According to TipRanks data, the analyst has a success
Express News | CARGO Therapeutics Inc : Chardan Capital Markets Initiates With Buy Rating and $28 Price Target
Buy Rating Affirmed for CARGO Therapeutics on Promising CAR-T Advancements and Strategic Positioning
Chardan Initiates CARGO Therapeutics at Buy With $28 Price Target
06:22 AM EDT, 07/08/2024 (MT Newswires) -- Chardan Initiates CARGO Therapeutics at Buy With $28 Price Target
Piper Sandler Initiates CARGO Therapeutics(CRGX.US) With Buy Rating, Announces Target Price $37
Piper Sandler analyst Biren Amin initiates coverage on $CARGO Therapeutics(CRGX.US)$ with a buy rating, and sets the target price at $37.According to TipRanks data, the analyst has a success rate of 4
Express News | CARGO Therapeutics Inc : Piper Sandler Initiates Coverage With Overweight Rating; Target Price $37
Express News | CARGO Therapeutics: Files for Prospectus Related to Resale by Selling Stockholders of up to 6.5 Mln Shares of Common Stock- SEC Filing
Express News | CARGO Therapeutics Inc - Board Approved an Increase in Number of Authorized Directors on Board From Seven to Eight
Express News | CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors With the Appointment of Jane Pritchett Henderson as Independent Director
$4M Bet On This Health Care Stock? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed mixed on Monday, there were a few notable insider trades.When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock
Cargo Therapeutics Shares Drop 17% After Private Placement News
By Stephen Nakrosis Shares of biotechnology company Cargo Therapeutics were trading in the red late in Tuesday's regular session, following news the company entered a securities purchase agreement fo
Express News | CARGO Therapeutics Shares Are Trading Lower After the Company Announced It Entered Into a Securities Purchase Agreement for a Private Investment in Public Equity Financing That Is Expected to Result in Gross Proceeds of Approximately $110.0 Million
Express News | CARGO Therapeutics Entered Into Security Purchase Agreement For Private Investment With Expectations To Result In Gross Proceeds Of ~ $110.0M
CARGO Therapeutics to Participate in Upcoming Investor Conferences
SAN CARLOS, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ:CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer
No Data